Class solution for inversely planned permanent prostate implants to mimic an experienced dosimetrist.

The purpose of this paper is to present a method for the selection of inverse planning parameters and to establish a set of inverse planning parameters (class solution) for the inverse planning included in a commercial permanent prostate implant treatment planning system. The manual planning of more than 750 patients since 1996 led to the establishment of general treatment planning rules. A class solution is tuned to fulfill the treatment planning rules and generate equivalent implants. For ten patients, the inverse planning is compared with manual planning performed by our experienced physicist. The prostate volumes ranged from 17 to 51cc and are implanted with low activity I-125 seeds. Dosimetric indices are calculated for comparison. The inverse planning needed about 15s for each optimization (400000 iterations on a 2.5GHz PC). In comparison, the physicist needed about 20min to perform each manual plan. A class solution is found that consistently produces dosimetric indices equivalent or better than the manual planning. Moreover, even with strict seed placement rules, the inverse planning can produce adequate prostate dose coverage and organ at risk protection. The inverse planning avoids implant with seeds outside of the prostate and too close to the urethra. It also avoids needles with only one seed and needles with three consecutive seeds. This reduces the risk of complication due to seed misplacement and edema. The inverse planning also uses a smaller number of needles, reducing the cause of trauma. The quality of the treatment plans is independent of the gland size and shape. A class solution is established that consistently and rapidly produces equivalent dosimetric indices as manual planning while respecting severe seed placement rules. The class solution can be used as a starting point for every patient, dramatically reducing the time needed to plan individual patient treatments. The class solution works with inverse preplanning, intraoperative inverse preplanning, and intraoperative real-time planning. This technology is not intended to replace the physicist but to accelerate the planning process, making intraoperative treatment planning more effective.

[1]  Haakon Ragde,et al.  Modern prostate brachytherapy , 2000 .

[2]  Charles H Albrecht 10-year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapy: in regard to Grimm et al., IJROBP 2001;51:31-40. , 2002, International journal of radiation oncology, biology, physics.

[3]  R. Sloboda,et al.  Optimization of brachytherapy dose distributions by simulated annealing. , 1992, Medical physics.

[4]  J P Logue,et al.  Development of a simultaneous boost IMRT class solution for a hypofractionated prostate cancer protocol. , 2004, The British journal of radiology.

[5]  Y. Yu,et al.  Intraoperative planning and evaluation of permanent prostate brachytherapy: report of the American Brachytherapy Society. , 2001, International journal of radiation oncology, biology, physics.

[6]  S. Webb,et al.  Class solutions for conformal external beam prostate radiotherapy. , 2003, International journal of radiation oncology, biology, physics.

[7]  Etienne Lessard Development and clinical introduction of an inverse planning dose optimization by simulated annealing (IPSA) for high dose rate brachytherapy , 2004 .

[8]  P. Xia,et al.  A study of planning dose constraints for treatment of nasopharyngeal carcinoma using a commercial inverse treatment planning system. , 2004, International journal of radiation oncology, biology, physics.

[9]  Julie Dawson,et al.  Dose effects of seeds placement deviations from pre-planned positions in ultrasound guided prostate implants , 1994 .

[10]  Jean Pouliot,et al.  Inverse planning for interstitial gynecologic template brachytherapy: truly anatomy-based planning. , 2002, International journal of radiation oncology, biology, physics.

[11]  C. N. Coleman,et al.  MRI-guided HDR prostate brachytherapy in standard 1.5T scanner. , 2004, International journal of radiation oncology, biology, physics.

[12]  R Nath,et al.  Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64. , 1999, Medical physics.

[13]  J Pouliot,et al.  Inverse planning anatomy-based dose optimization for HDR-brachytherapy of the prostate using fast simulated annealing algorithm and dedicated objective function. , 2001, Medical physics.

[14]  Blasko,et al.  10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy. , 2001, International journal of radiation oncology, biology, physics.

[15]  Jean Pouliot,et al.  The robustness of dose distributions to displacement and migration of 125I permanent seed implants over a wide range of seed number, activity, and designs. , 2004, International journal of radiation oncology, biology, physics.

[16]  J. Pouliot,et al.  Early clinical experience with anatomy-based inverse planning dose optimization for high-dose-rate boost of the prostate. , 2002, International journal of radiation oncology, biology, physics.

[17]  C. Clifton Ling,et al.  Determining source strength and source distribution for a transperineal prostate implant , 1996 .

[18]  A. Redpath Automatic determination of needle and source positions for brachytherapy of the prostate using 125Iodine Rapid Strand. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  Jean Pouliot,et al.  Comparison of inverse planning simulated annealing and geometrical optimization for prostate high-dose-rate brachytherapy. , 2004, Brachytherapy.

[20]  J. Ciezki,et al.  Dosimetric comparison of pre-planned and or-planned prostate seed brachytherapy. , 2000, International journal of radiation oncology, biology, physics.

[21]  H. Ragde,et al.  Modern prostate brachytherapy , 2000 .

[22]  J. Pouliot,et al.  Optimization of permanent 125I prostate implants using fast simulated annealing. , 1996, International journal of radiation oncology, biology, physics.

[23]  D. Brachman,et al.  Failure-free survival following brachytherapy alone or external beam irradiation alone for T1-2 prostate tumors in 2222 patients: results from a single practice. , 2000, International journal of radiation oncology, biology, physics.

[24]  D. Beyer,et al.  Real-time optimized intraoperative dosimetry for prostate brachytherapy: a pilot study. , 2000, International journal of radiation oncology, biology, physics.

[25]  Mark J. Rivard,et al.  A technical evaluation of the Nucletron FIRST system: Conformance of a remote afterloading brachytherapy seed implantation system to manufacturer specifications and AAPM Task Group report recommendations , 2005, Journal of applied clinical medical physics.

[26]  R. Taschereau,et al.  Seed misplacement and stabilizing needles in transperineal permanent prostate implants. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  P. Okunieff,et al.  Intraoperative optimized inverse planning for prostate brachytherapy: early experience. , 1999, International journal of radiation oncology, biology, physics.

[28]  Jean Pouliot,et al.  3D inverse treatment planning for the tandem and ovoid applicator in cervical cancer. , 2005, International journal of radiation oncology, biology, physics.

[29]  Y. Yamada,et al.  Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy. , 2003, International journal of radiation oncology, biology, physics.

[30]  P. Roberson,et al.  Source placement error for permanent implant of the prostate. , 1997, Medical physics.

[31]  I. Hsu,et al.  Prostate volume change after radioactive seed implantation: possible benefit of improved dose volume histogram with perioperative steroid. , 2000, International journal of radiation oncology, biology, physics.

[32]  J. Cygler,et al.  Correlating the degree of needle trauma during prostate brachytherapy and the development of acute urinary toxicity. , 2004, International journal of radiation oncology, biology, physics.